The Technical Analyst
Select Language :
Royalty Pharma plc [RPRX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Royalty Pharma plc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Royalty Pharma plc is listed at the  Exchange

-0.26% $30.37

America/New_York / 28 mar 2024 @ 16:00


Royalty Pharma plc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 13 566 mill
EPS: 2.53
P/E: 12.00
Earnings Date: May 06, 2024
SharesOutstanding: 446.69 mill
Avg Daily Volume: 2.66 mill
RATING 2024-03-28
S
Strong Buy
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Buy
Return On Asset: Strong Buy
DE: Strong Buy
P/E: Strong Buy
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 12.00 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
2.04x
Company: PE 12.00 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$78.90
(159.81%) $48.53
Date: 2024-03-28
Expected Trading Range (DAY)

$ 29.66 - 31.08

( +/- 2.34%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-20 Riggs Rory B Buy 300 000 Class A Ordinary Shares
2024-02-20 Riggs Rory B Sell 30 000 LP interests in RPI US Partners 2019, LP
2024-01-02 Riggs Rory B Sell 235 200 Class A Ordinary Shares
2024-01-03 Riggs Rory B Sell 199 098 Class A Ordinary Shares
2024-01-04 Riggs Rory B Sell 35 702 Class A Ordinary Shares
INSIDER POWER
-37.16
Last 100 transactions
Buy: 3 305 882 | Sell: 7 663 240

Forecast: 16:00 - $30.39

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $30.39
Forecast 2: 16:00 - $30.39
Forecast 3: 16:00 - $30.39
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $30.37 (-0.26% )
Volume 2.71 mill
Avg. Vol. 2.66 mill
% of Avg. Vol 102.06 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Royalty Pharma plc

Last 12 Months

Last 12 months chart data with high, low, open and close for Royalty Pharma plc

RSI

Intraday RSI14 chart for Royalty Pharma plc

Last 10 Buy & Sell Signals For RPRX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$28.55N/AActive
Profile picture for
            Royalty Pharma plc

RPRX

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Last 10 Buy Signals

Date Signal @
RBTCUSDMar 28 - 17:57$70 251
ORNUSDMar 28 - 17:59$2.31
YFIUSDMar 28 - 17:57$8 975.00
RAYUSDMar 28 - 17:56$2.00
SFUNDUSDMar 28 - 17:53$4.37
UNFIUSDMar 28 - 17:537.51
RIOUSDMar 28 - 17:542.90
MSOLUSDMar 28 - 17:53220.98
METISUSDMar 28 - 17:55$100.67
LINKUSDMar 28 - 17:55$19.18

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.